Latent HIV-1 can be reactivated by superinfection in a Tat-dependent manner, which can lead to the emergence of recombinant viruses by unknown
POSTER PRESENTATION Open Access
Latent HIV-1 can be reactivated by superinfection
in a Tat-dependent manner, which can lead
to the emergence of recombinant viruses
Daniel Aaron Donahue1*, Sophie M Bastarache1, Richard D Sloan2, Mark A Wainberg1
From Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts
Cambridge, UK. 16-18 September 2013
Background
The HIV-1 latent reservoir represents an important source
of genetic diversity that could contribute to viral evolution
and drug resistance. Latent virus reactivation might occur
by superinfection of latently infected cells. Previous studies
have suggested that latent viruses contribute to recombina-
tion in vivo, but this has not been experimentally studied.
Methods
We used both Jurkat and primary cell latency models. In
Jurkat cells, wt and drug-resistant latent populations
were superinfected with wt or drug-resistant viruses,
including nef or tat mutants, and treated with various
inhibitors. Viral reporter gene expression was measured
by FACS. Sequence tags on each resistant virus per-
mitted identification of recombinants. We also per-
formed superinfection experiments in primary cells.
Results
Latent viruses were reactivated by superinfection in both
latency models. In Jurkat cells, the extent of latent virus
reactivation was strongly correlated (r2 = 0.98) with the
extent of superinfection across a wide range of viral
inocula. Latent virus reactivation required gene expression
of the superinfecting virus, since latent viruses were reacti-
vated in the presence of a protease inhibitor, but not a
reverse transcriptase (RT) or integrase inhibitor. Latent
virus reactivation occurred following superinfection with
nef-deleted or tat-attenuated, but not tat-inactivated,
viruses. These results suggest that neither gp120-induced
CD4/CXCR4 signalling nor Nef-induced NFkB/NFAT
modulation were required for latent virus reactivation, but
that superinfecting virus Tat was required. Drug-resistant
latent viruses (RT K103N) were reactivated following
superinfection with additional drug resistant viruses (RT
M184V). The resulting supernatants (containing heterozy-
gous virions) were used to infect new cells, to which the
RT inhibitors FTC and EFV were added. Sequencing and
restriction digestion confirmed that recombination fre-
quently occurred, leading to FTC/EFV-resistant virions
encoding unique sequence tags derived from both parental
viruses. We also established latency in unstimulated pri-
mary CD4T-cells and subjected them to superinfection.
Results from nine individual donors indicate that latent
viruses were reactivated by superinfection; these results
were statistically significant (p=0.001).
Conclusions
Our results suggest that superinfection of latently infected
cells can reactivate latent viruses, which can then recom-
bine with the superinfecting virus. Since all viral quasispe-
cies including drug-resistant viruses can be latently
archived, reactivation of latent viruses by superinfection or
other means could contribute to the emergence of replica-
tively fit viruses in the face of strong selective pressures.
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